Neupro 3 MG/Day 24HR Transdermal System

RxCUI
1251918
RxNorm name
Neupro 3 MG/Day 24HR Transdermal System
Display name
Neupro 3 MG/Day 24HR Transdermal System
Full name
Neupro 3 MG/Day 24HR Transdermal System
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:08

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
NeuproROTIGOTINEUCB, Inc.939e28c5-f3a9-42c0-9a2d-8d471d82a6e02025-06-24Warnings, Adverse reactionsExact identifier
rxcui: 1251918

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
939e28c5-f3a9-42c0-9a2d-8d471d82a6e0Neupro 3 MG/Day 24HR Transdermal SystemSY20These highlights do not include all the information needed to use NEUPRO safely and effectively. See full prescribing information for NEUPRO. NEUPRO (rotigotine transdermal system) Initial U.S. Approval: 200720250624
939e28c5-f3a9-42c0-9a2d-8d471d82a6e0Neupro 3 MG/Day 24 HR Transdermal PatchSY20These highlights do not include all the information needed to use NEUPRO safely and effectively. See full prescribing information for NEUPRO. NEUPRO (rotigotine transdermal system) Initial U.S. Approval: 200720250624
939e28c5-f3a9-42c0-9a2d-8d471d82a6e0Neupro 3 MG/Day 24HR Transdermal SystemPSN20These highlights do not include all the information needed to use NEUPRO safely and effectively. See full prescribing information for NEUPRO. NEUPRO (rotigotine transdermal system) Initial U.S. Approval: 200720250624
939e28c5-f3a9-42c0-9a2d-8d471d82a6e024 HR Neupro 0.125 MG/HR Transdermal SystemSY20These highlights do not include all the information needed to use NEUPRO safely and effectively. See full prescribing information for NEUPRO. NEUPRO (rotigotine transdermal system) Initial U.S. Approval: 200720250624
939e28c5-f3a9-42c0-9a2d-8d471d82a6e024 HR rotigotine 0.125 MG/HR Transdermal System [Neupro]SBD20These highlights do not include all the information needed to use NEUPRO safely and effectively. See full prescribing information for NEUPRO. NEUPRO (rotigotine transdermal system) Initial U.S. Approval: 200720250624